Subscribe
shutterstock_1524073421_karol_ciesluk
Karol Ciesluk / Shutterstock.com
27 February 2020AmericasSarah Morgan

Vir Biotech partners with WuXi on COVID-19 antibody treatment

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.


Editor's picks

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025

Editor's picks

Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More features

Fed Circ: Generic doesn’t infringe Metacel MS drug
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
Strategic IP protection for biotech-related GenAI
South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
In vivo cell therapy: A world beyond ex vivo engineering
Patent litigator with biotech and medical device background joins Sterlington
Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency
Fenwick establishes new Boston office with trio of IP partners from Cooley